ライフサイエンスコーパス: cardiac surgery

1 the most severe and feared complications of cardiac surgery.

2 openings on SSI risk in patients undergoing cardiac surgery.

3 sthesia for any in-hospital procedure except cardiac surgery.

4 postoperative pulmonary complications after cardiac surgery.

5 patients with acquired hypofibrinogenemia in cardiac surgery.

6 nts with prolonged ICU stays following major cardiac surgery.

7 e delirium in patients admitted for elective cardiac surgery.

8 long-term survival among patients undergoing cardiac surgery.

9 (IQR, 32-54), and 44% of patients underwent cardiac surgery.

10 st-operative recovery in neonates undergoing cardiac surgery.

11 a pilot trial including patients undergoing cardiac surgery.

12 th native valve MR who were at high risk for cardiac surgery.

13 reducing the time to recovery from AKI after cardiac surgery.

14 of developing dementia within 5 years after cardiac surgery.

15 ny patients at extreme risk for conventional cardiac surgery.

16 ildren undergoing cardiopulmonary bypass for cardiac surgery.

17 actors for retinal artery occlusion (RAO) in cardiac surgery.

18 ective cohort study of 968 adults undergoing cardiac surgery.

19 ntion during non-atrial fibrillation-related cardiac surgery.

20 life-threatening bleeding, especially during cardiac surgery.

21 The NIS was searched for cardiac surgery.

22 severe complication of critical illness and cardiac surgery.

23 ng to septic air emboli and requiring urgent cardiac surgery.

24 s in critically ill adults or children after cardiac surgery.

25 enty-four sequential patients admitted after cardiac surgery.

26 nated heater-cooler units (HCUs) used during cardiac surgery.

27 (CV) events and mortality in patients after cardiac surgery.

28 Twenty-three percent of patients underwent cardiac surgery.

29 nist, in patients at high risk for AKI after cardiac surgery.

30 treat the low cardiac output syndrome after cardiac surgery.

31 ents exposed to beta-blockers undergoing non-cardiac surgery.

32 development of dementia within 5 years after cardiac surgery.

33 e perioperative outcome in adults undergoing cardiac surgery.

34 with congenital heart disease, and 54% after cardiac surgery.

35 itioning (RIPC) in patients undergoing adult cardiac surgery.

36 tion and delirium are common consequences of cardiac surgery.

37 discharge was less prevalent after PCI than cardiac surgery.

38 %) were conducted at centers without on-site cardiac surgery.

39 morbidity/mortality for children undergoing cardiac surgery.

40 r rate of survival among patients undergoing cardiac surgery.

41 sociated with mortality in the 30 days after cardiac surgery.

42 d in younger patients undergoing non-complex cardiac surgery.

43 nded to reduce pulmonary complications after cardiac surgery.

44 similar at centers with and without on-site cardiac surgery.

45 acute myocardial infarction and after major cardiac surgery.

46 n of statin therapy to prevent AKI following cardiac surgery.

47 functional decline after minimally invasive cardiac surgery.

48 ranting long-term follow-up after congenital cardiac surgery.

49 mplications in high-risk patients undergoing cardiac surgery.

50 ertension are common 5 years after pediatric cardiac surgery.

51 0.3 mg/dL or more during hospitalization for cardiac surgery.

52 fibrillation or delirium in patients having cardiac surgery.

53 is a common and troublesome complication of cardiac surgery.

54 rred in 1 patient who had undergone previous cardiac surgery.

55 t atrial samples from patients who underwent cardiac surgery.

56 ion, age, sex, serum creatinine, trauma, and cardiac surgery.

57 th catheters for minimally invasive forms of cardiac surgery.

58 toperative management of children undergoing cardiac surgery.

59 mias or delirium in patients recovering from cardiac surgery.

60 urgery, surgery on thoracic aorta, and other cardiac surgery.

61 cessive bleeding is a common complication of cardiac surgery.

62 of shock and/or hypoperfusion within 12h of cardiac surgery.

63 ablished risk indices in patients undergoing cardiac surgery.

64 break) was performed for up to 2 weeks after cardiac surgery.

65 define long-term quality and the benefit of cardiac surgery.

66 ) occurs in up to 40% of patients undergoing cardiac surgery.

67 Mycobacterium chimaera infections following cardiac surgeries.

68 urgery compared with centers without on-site cardiac surgery (1.4% vs 1.9%; unadjusted odds ratio [OR

69 mol/L [131-193 pmol/L]; p = 0.039) and after cardiac surgery (173 pmol/L [129-217 pmol/L] vs 143 pmol

70 %, P<0.001) and had higher rates of previous cardiac surgery (18% versus 12%, P<0.001), chronic obstr

71 F precipitant, the most common of which were cardiac surgery (22%), pneumonia (20%), and noncardiotho

72 ed in ICU setting (2,857 patients) and 28 in cardiac surgery (3,598 patients), published between 1995

73 nce the Fontan procedure included additional cardiac surgery (32%), catheter intervention (62%), arrh

74 s (11.1 versus 11.4 g/dL; P=0.005), previous cardiac surgery (47.8% versus 39.8%; P=0.004), history o

75 Among patients undergoing cardiac surgery, a restrictive transfusion approach resu

76 tive hemodynamic support was indicated after cardiac surgery, according to prespecified criteria.

77 In these patients with AKI after cardiac surgery, administration of allogeneic MSCs did n

78 ith intraoperative bleeding during high-risk cardiac surgery, administration of fibrinogen concentrat

79 l success (<=2+ residual MR without death or cardiac surgery) also increased with operator experience

80 ality are lower in obese patients undergoing cardiac surgery, although the nature of this association

81 A total of 9,372 patients underwent 11,968 cardiac surgeries and 1,912 catheter-based interventions

82 th postoperative AF (5-year incidence 32% in cardiac surgery and 39% in noncardiothoracic surgery).

83 onary angiography and patients who underwent cardiac surgery and at the time of admission to the inte

84 All patients undergoing cardiac surgery and congenital interventions in the Unit

85 rts with normal systolic function undergoing cardiac surgery and donating LV biopsy (non-pressure-loa

86 occurs in 30% to 50% of patients undergoing cardiac surgery and is associated with increased morbidi

87 cular dysfunction is a major complication of cardiac surgery and is associated with increased mortali

88 trial fibrillation commonly occurs following cardiac surgery and is associated with increased rates o

89 is associated with a poor outcome following cardiac surgery and is generally modified by the use of

90 rging but remain behind adult cardiology and cardiac surgery and leading to partial blindness as to t

91 Postoperative delirium is common following cardiac surgery and may be affected by choice of analges

92 m multivessel disease patients in New York's cardiac surgery and percutaneous coronary intervention r

93 e most important challenges faced by RCTs in cardiac surgery and provides a list of suggestions for t

94 ore commonly academic centers, had available cardiac surgery and rehabilitation services, and had hig

95 were obtained from 10 patients who underwent cardiac surgery and subjected to immunohistochemical ana

96 ars who underwent cardiopulmonary bypass for cardiac surgery and survived hospitalization from 3 Nort

97 ld improve the management of coagulopathy in cardiac surgery and thereby reduce blood transfusions.

98 es the incidence of AKI in adults undergoing cardiac surgery and this benefit was more pronounced in

99 and adverse outcomes in patients undergoing cardiac surgery and to derive and validate prognosis-bas

100 icular tissue from human patients undergoing cardiac surgery and used RNA sequencing to describe an l

101 shock occurs in 2-6% of patients undergoing cardiac surgery, and 1% of cardiac surgery patients will

102 oronary angiography, 250 who were undergoing cardiac surgery, and 692 who were critically ill.

103 prevalence of frailty in patients undergoing cardiac surgery, and a statistically significant associa

104 determine the mechanism of chylothorax after cardiac surgery, and analyze the outcomes of lymphatic e

105 eimplant tricuspid regurgitation, history of cardiac surgery, and concomitant procedures other than t

106 but had less coronary disease, less previous cardiac surgery, and higher ejection fraction than men.

107 year were classified as centers with on-site cardiac surgery, and weighted sampling of all inpatient

108 notypes are sepsis with acute kidney injury, cardiac surgery, anemia, respiratory failure, heart fail

109 Complications after cardiac surgery are common and lead to substantial incre

110 itically ill children who have not undergone cardiac surgery are lacking.

111 ound protamine-already used clinically after cardiac surgery-as an agent to bind to heparin and there

112 ith heme toxicity as a pathogenic feature of cardiac surgery-associated AKI, and with HO-1 as a poten

113 on registry regarding patients who underwent cardiac surgery at <15 years of age at 1 of 5 universiti

114 ty one consecutive adult patients undergoing cardiac surgery at 3 hospitals in the United States and

115 nical trial of patients with hypoxemia after cardiac surgery at a single ICU in Brazil (December 2011

116 prised consecutive patients who had elective cardiac surgery at the Saarland University Medical Centr

117 ew Oral Anticoagulants vs. Warfarin for post Cardiac Surgery Atrial Fibrillation: The NEW-AF Trial.

118 In cardiac surgery, beneficial effects on postoperative atr

119 ents greater than 18 years old who underwent cardiac surgery between January 1, 2006, and April 30, 2

120 th ischemic heart disease, heart failure, or cardiac surgery but are significantly underused, with on

121 arrest (HCA) provides neuroprotection during cardiac surgery but entails an ischemic period that can

122 e risk of bleeding among patients undergoing cardiac surgery, but it is unclear whether this leads to

123 spitalization and mortality following infant cardiac surgery, but therapeutic options are limited.

124 handoffs improves information transfer after cardiac surgery, but there is limited evidence in other

125 tional cardiology, interventional radiology, cardiac surgery, cardiac imaging, and critical care.

126 ients undergoing CABG at 16 Veterans Affairs cardiac surgery centers to either open or endoscopic vei

127 significantly lower at centers with on-site cardiac surgery compared with centers without on-site ca

128 r associate with increased risk of AKI after cardiac surgery, consistent with heme toxicity as a path

129 biomarkers and clinical factors pre and post cardiac surgery could stratify patients at risk of devel

130 We obtained data from a nationwide pediatric cardiac surgery database and Finnish population registry

131 We assessed the impact of cardiac surgery, discharge location, and Society of Thor

132 t dexamethasone-compared with placebo-during cardiac surgery does not positively or negatively affect

133 cutive series of patients operated of urgent cardiac surgery during COVID-19 outbreak.

134 After cardiac surgery, electrodes were applied in the triangul

135 composite of all-cause mortality, unplanned cardiac surgery, embolic events, or relapse of bacteremi

136 cutoff to define elderly is controversial in cardiac surgery, empirically ranging from >/=65 to >/=80

137 e SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) (enrollment period 2005 to 2007) and EX

138 SYNTAXES (Synergy between PCI with Taxus and Cardiac Surgery Extended Survival) trial.

139 rials (RCTs) in medical specialties, RCTs in cardiac surgery face specific issues.

140 rated health system interventions, including cardiac surgery for congenital and rheumatic heart disea

141 s from children of different ages undergoing cardiac surgery for congenital heart defects were isolat

142 s from children of different ages undergoing cardiac surgery for congenital heart defects were isolat

143 roportion of PCIs at centers without on-site cardiac surgery from 2003 to 2012 in the United States,

144 Data on adult cardiac surgery from 2007 to 2012 (n=95 240) were extrac

145 samples were prospectively collected during cardiac surgery from 239 patients enrolled in the OPERA

146 rial compared methods of fluid removal after cardiac surgery from October 1, 2011, through March 13,

147 involved during the intraoperative phase of cardiac surgery from the perspective of multiple operati

148 involved during the intraoperative phase of cardiac surgery from the perspective of multiple OR team

149 ficant bleeding and hypofibrinogenemia after cardiac surgery (from February 10, 2017, to November 1,

150 ata Register sTudies of Risk and Outcomes in Cardiac Surgery [HARTROCS]; NCT02276950).

151 matching of male and female participants and cardiac surgery having the worst.

152 gher restrictive threshold is recommended in cardiac surgery (hemoglobin < 7.5 g/dL) and stable cardi

153 In sinus rhythm patients undergoing cardiac surgery, histopathologic changes in the right at

154 Cardiac surgery ICU characteristics and clinician staffi

155 Pennsylvania cardiac surgery ICUs have variable structures, care prac

156 From 2012 to 2013, we conducted a survey of cardiac surgery ICUs in Pennsylvania to assess ICU struc

157 Cardiac surgery ICUs in Pennsylvania.

158 ted from the medical, surgical, cardiac, and cardiac surgery ICUs of a tertiary medical center in the

159 ving patients undergoing elective, high-risk cardiac surgery (ie, combined coronary artery bypass gra

160 udy involved consecutive patients undergoing cardiac surgery in 2 prespecified ORs equipped with auto

161 ional cohort study included patients who had cardiac surgery in a derivation cohort and those who had

162 ery in a derivation cohort and those who had cardiac surgery in a validation cohort (RenalRIP trial).

163 of inpatient PCI at centers without on-site cardiac surgery in an unselected and nationally represen

164 ncidence, severity, or duration of AKI after cardiac surgery in high-risk patients.

165 During CPB with cardiac surgery in sheep, the clinical applicability of

166 Early mortality for cardiac surgery in the neonatal period is approximately

167 all nonfederal hospitals performing PCI and cardiac surgery in Washington State.

168 Risk factors for RAO in cardiac surgery include giant cell arteritis, carotid st

169 nagement of patients with CAD undergoing non-cardiac surgery, including those treated with stents.

170 l success (<=1+ residual MR without death or cardiac surgery) increased across categories of operator

171 postoperative pulmonary complications after cardiac surgery independently of indicators of frailty,

172 sepsis trials but has not been evaluated for cardiac surgery-induced AKI.

173 Cardiac surgery is associated with a high risk of postop

174 Low cardiac output syndrome after cardiac surgery is associated with high morbidity and mo

175 AKI after cardiac surgery is associated with mortality, prolonged

176 mine whether the obesity paradox observed in cardiac surgery is attributable to reverse epidemiology,

177 ming of discontinuation of ticagrelor before cardiac surgery is controversial.

178 lts suggest that clinical AKI at the time of cardiac surgery is indicative of concurrent CV stress ra

179 erative death following pediatric congenital cardiac surgery is lacking.

180 We have learned that SCT and cardiac surgery is not a benign combination.

181 ve Risk Evaluation II in patients undergoing cardiac surgery is not known.

182 -term patient-reported quality of life after cardiac surgery is not well understood.

183 ntervention (PCI) at centers without on-site cardiac surgery is safe outside of a tightly regulated r

184 by extracorporeal membrane oxygenation after cardiac surgery is uncertain.

185 The cardiac surgery literature consists mostly of small, sin

186 ired perioperative hemodynamic support after cardiac surgery, low-dose levosimendan in addition to st

187 Patients (N=212) undergoing cardiac surgery (male:161, 63+/-11 years) underwent epic

188 evidence that PCI at centers without on-site cardiac surgery may be safe in the modern era.

189 diographic diagnosis, and swift referral for cardiac surgery might impact outcome dramatically.

190 gionella), and heater-cooler devices used in cardiac surgery (Mycobacterium chimaera).

191 cteristics (RM versus LAT: prior ablation or cardiac surgery n=35 [83%] versus n=35 [85%], P=0.80).

192 tients (n=12) and non-HF subjects undergoing cardiac surgery (n=12) treated with beta-AR blockers rev

193 he culture of removed cardiac tissues during cardiac surgery of left-sided infective endocarditis (LS

194 timizing facility-based postacute care after cardiac surgery offers unique opportunities to reduce po

195 Patients with prior cardiac surgery or pre-existing PPM were excluded.

196 re updated with 1 or 3 years of data, in all cardiac surgery or within operation subgroups.

197 dence interval [CI], 1.04-1.42; P = .01) and cardiac surgery (OR, 0.24; 95% CI, .09-.63; P = .04) wer

198 ity between centers with and without on-site cardiac surgery (OR, 1.01; 95% CI, 0.98-1.03; P = .62) f

199 ocardial infarction, stroke, death, emergent cardiac surgery, or clinically significant perforation),

200 ociated with hemodynamic compromise, sepsis, cardiac surgery, or exposure to nephrotoxins.

201 al appendage (LAA) is often performed during cardiac surgery ostensibly to reduce the risk of stroke.

202 ials, consistent with improving results with cardiac surgery over time.

203 morbidity and mortality associated with non-cardiac surgery, particularly in patients with coronary

204 were linked to an administrative database of cardiac surgery patient discharges.

205 of HF (n = 40), no-HF controls (n = 60), and cardiac surgery patients (n = 32).

206 mizing the options for stroke prophylaxis in cardiac surgery patients and catalyze more widespread ap

207 is combined retrospective/prospective study, cardiac surgery patients at an academic institution (201

208 ntrolled, randomized clinical trial of adult cardiac surgery patients conducted from November 2009 to

209 plasma GSNOR activity than did preoperative cardiac surgery patients or healthy volunteers ( P<0.000

210 e race and poor outcomes in small subsets of cardiac surgery patients who require extracorporeal life

211 tients undergoing cardiac surgery, and 1% of cardiac surgery patients will require mechanical circula

212 sma fibrinogen level of 2.5 g/L in high-risk cardiac surgery patients with intraoperative bleeding re

213 (December 2014-June 2015) cases occurred in cardiac surgery patients with invasive infections.

214 obtained from post-CA patients, preoperative cardiac surgery patients, and healthy volunteers.

215 Among cardiac surgery patients, combination prophylaxis was as

216 Among MRSA-negative and -unknown cardiac surgery patients, SSIs occurred in 58/6,607 (0.9

217 In cardiac surgery patients, the difference in risk-benefit

218 concentration and the development of AKI in cardiac surgery patients.

219 ) of PCI patients and 91% (21 831/23 972) of cardiac surgery patients.

220 ever, NOACs have yet to be adopted widely in cardiac surgery patients.

221 In cardiac surgery, pericardial adhesions are particularly

222 Among older patients undergoing cardiac surgery, postoperative scheduled IV acetaminophe

223 .94; 95% confidence interval, 4.10-9.49) and cardiac surgery (range 54%-100%; median odds ratio, 7.09

224 In-hospital complications and cardiac surgery rates significantly increased across the

225 e course of the last 20 years, the number of cardiac surgery RCTs has declined significantly.

226 ecruitment make the successful completion of cardiac surgery RCTs particularly challenging.

227 for the successful design and completion of cardiac surgery RCTs.

228 <7 g/dL) as well as for patients undergoing cardiac surgery (recommended threshold for RBC transfusi

229 Data from the National Adult Cardiac Surgery registry for all cardiac surgical proced

230 ents were prospectively added to a dedicated cardiac surgery registry.

231 Cardiac surgery-related patient isolates were all classi

232 We included 24 M chimaera isolates from 21 cardiac surgery-related patients in Switzerland, Germany

233 his subgroup also comprised isolates from 11 cardiac surgery-related patients reported from the USA,

234 Patients undergoing complex pediatric cardiac surgery remain at considerable risk of mortality

235 AKI after cardiac surgery remains strongly associated with mortali

236 on clinical outcomes in patients undergoing cardiac surgery remains unclear.

237 rs of age who were scheduled for nonemergent cardiac surgery requiring cardiopulmonary bypass and had

238 Cardiac surgery results in improved PROMIS scores at 1 y

239 taneous Coronary Intervention With Taxus and Cardiac Surgery) score (SS), a measure of anatomic coron

240 taneous Coronary Intervention With Taxus and Cardiac Surgery) score quantifies the extent of coronary

241 n SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) score was 19.7 +/- 9.6.

242 taneous Coronary Intervention With Taxus and Cardiac Surgery) scores and lesion characteristics were

243 vation cohort) and those undergoing elective cardiac surgery (selected on the basis of a Cleveland Cl

244 We analyzed PCI and cardiac surgery separately by performing multivariable h

245 Acute kidney injury (AKI) following cardiac surgery significantly increases morbidity and mo

246 ents with sickle cell trait (SCT) undergoing cardiac surgery, since it is recognized that cardiopulmo

247 In MRSA-colonized patients undergoing cardiac surgery, SSI occurred in 8/346 (2.3%) patients w

248 ermediate Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) score (random-effects: HR, 1.02

249 ed by the Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) score.

250 The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial was a non-inferiority tri

251 taneous Coronary Intervention With Taxus and Cardiac Surgery [SYNTAX]; NCT00114972).

252 (Synergy Between PCI With Taxus and Cardiac Surgery [SYNTAX]; NCT00114972; Evaluation of XIE

253 (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES], NC

254 (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES]; NC

255 Among patients with hypoxemia after cardiac surgery, the use of an intensive vs a moderate a

256 ores indicating a higher risk of death after cardiac surgery) to a restrictive red-cell transfusion t

257 ycemia (excluding patients who had undergone cardiac surgery) to one of two ranges of glycemic contro

258 Advances in cardiac surgery toward the mid-20th century created a ne

259 (Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions; NCT018452

260 taneous Coronary Intervention With Taxus and Cardiac Surgery) trial, patients with 3-vessel or left m

261 taneous Coronary Intervention With Taxus and Cardiac Surgery) trial, the effect of treatment with per

262 an 60 years undergoing major cardiac and non-cardiac surgery under general anaesthesia.

263 ative atrial fibrillation who are undergoing cardiac surgery undergo concomitant atrial fibrillation

264 xplained only 10% of PCI variation and 0% of cardiac surgery variation.

265 In cardiac surgery, vitamin C was associated to a reduction

266 increased mean door opening frequency during cardiac surgery was associated with higher risk for cons

267 Cardiac surgery was less frequently performed in EE (40.

268 Occurrence of an SSI within 30 days after cardiac surgery was our primary outcome measure.

269 allocation bias, LAA closure during routine cardiac surgery was significantly associated with an inc

270 en recovering in PICU after having undergone cardiac surgery, we found that milrinone acted as a vaso

271 infarction, or an indication for concomitant cardiac surgery were excluded.

272 796 consecutive adult patients who underwent cardiac surgery were included in the study, and 347 (7.2

273 rteen patients with persistent AF undergoing cardiac surgery were included.

274 Frequent door openings during cardiac surgery were independently associated with an in

275 = 401) consecutively scheduled for elective cardiac surgery were prospectively studied.

276 ement combining antibiotic therapy and early cardiac surgery when indicated.

277 of brain injury is increased during neonatal cardiac surgery, where pre-existing hemodynamic instabil

278 llation (POAF) is a frequent complication of cardiac surgery, which results in increased morbidity, m

279 l variation in postacute care spending after cardiac surgery, which was primarily driven by different

280 nts with new onset atrial fibrillation after cardiac surgery who are treated with NOACs versus Warfar

281 In patients undergoing cardiac surgery who develop clinically significant bleed

282 we randomly assigned 5243 adults undergoing cardiac surgery who had a European System for Cardiac Op

283 In patients undergoing cardiac surgery who were at moderate-to-high risk for de

284 algorithm in consecutive patients undergoing cardiac surgery with cardiopulmonary bypass at 12 hospit

285 Neonates undergoing cardiac surgery with cardiopulmonary bypass at 2 centers

286 Patients who had had cardiac surgery with cardiopulmonary bypass were enrolle

287 We studied 4531 patients undergoing cardiac surgery with cardiopulmonary bypass who had a mo

288 ive AKI in 2377 white patients who underwent cardiac surgery with cardiopulmonary bypass.

289 eligible infants (aged <6 months) undergoing cardiac surgery with catheter placement for PD were appr

290 ing cell-free (cf)DNA in patients undergoing cardiac surgery with CPB.

291 We randomized 156 adult subjects undergoing cardiac surgery with evidence of early AKI to receive in

292 rillary acidic protein (GFAP) after elective cardiac surgery with the implementation of cardiopulmona

293 fraction of 35% or less who were undergoing cardiac surgery with the use of cardiopulmonary bypass.

294 icular ejection fraction who were undergoing cardiac surgery with the use of cardiopulmonary bypass.

295 Obesity is associated with lower risks after cardiac surgery, with consistent effects noted in multip

296 Infants with single ventricle require staged cardiac surgery, with stage I typically performed shortl

297 oing coronary stent implantation require non-cardiac surgery within 2 years, surgery is the most comm

298 roportion of PCIs at centers without on-site cardiac surgery within the study period (from 1.8% to 12

299 ion (n = 30) and controls (n = 58) (elective cardiac surgery without infection).

300 mber needed to harm for severe AKI following cardiac surgery would be 167.